|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-36S1
|
$125,000
|
$2,500
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-36
|
$2,600,006
|
$52,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-02
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
3U10CA180864-01S1
|
$70,000
|
$1,400
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
5U10CA180864-02
|
$620,949
|
$12,419
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Whole Genome Sequencing to Discover Familial Myeloma Risk Genes
|
5R01CA167824-04
|
$350,675
|
$350,675
|
LIPKIN, STEVEN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-02
|
$1,549,280
|
$77,464
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Ou
|
ZIA CP010126 - 00580
|
$39,863
|
$1,993
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-02
|
$528,806
|
$13,220
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
Validation of the Fes Tyrosine Kinase as an Inhibitor Target in Multiple Myeloma
|
1R21CA185702-01A1
|
$167,475
|
$167,475
|
SMITHGALL, THOMAS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validating the eCyPA/CD147 signaling complex for myeloma therapy
|
1R01CA196783-01
|
$393,715
|
$393,715
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INST
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
$1,497
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
$5,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
$171,540
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UTX, MLL and Pathogenic Deregulation of Histone Methylation in Multiple Myeloma
|
5R01CA180475-02
|
$359,416
|
$359,416
|
LICHT, JONATHAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-02
|
$700,000
|
$8,750
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
3U10CA180858-02S1
|
$100,000
|
$2,000
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-02
|
$1,192,600
|
$23,852
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S1
|
$62,500
|
$625
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S2
|
$50,000
|
$500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-40
|
$6,231,178
|
$62,312
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S1
|
$395,573
|
$3,956
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S2
|
$124,964
|
$1,250
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S3
|
$68,339
|
$683
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S4
|
$200,000
|
$2,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-08
|
$1,535,000
|
$15,350
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-03S1
|
$250,000
|
$7,500
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-03S2
|
$125,000
|
$3,750
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
5P30CA177558-03
|
$1,505,000
|
$45,150
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
UM LAPs- U10 Grant
|
5U10CA180801-02
|
$684,929
|
$68,493
|
ZALUPSKI, MARK
|
UNIVERSITY OF MICHIGAN
|
|
UCDCCC NCTN U10 Program
|
3U10CA180846-02S1
|
$99,708
|
$2,493
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-02
|
$630,226
|
$15,756
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Ubiquitin signaling for protein degradation
|
ZIA BC 011490
|
$665,078
|
$598,570
|
Walters, Kylie
|
CCR (NCI)
|
|
Tumor Cell-Intrinsic/Extrinsic Mechanisms Underlying Myeloma Disease Progression
|
1R01CA196831-01
|
$363,713
|
$363,713
|
JELINEK, DIANE
|
MAYO CLINIC ROCHESTER
|
|
Transplant Models
|
ZIA BC 010957
|
$912,450
|
$273,735
|
Gress, Ronald
|
CCR (NCI)
|
|
Translation of Novel Therapeutic Targets in Multiple Myeloma
|
5R01CA167511-03
|
$431,907
|
$431,907
|
STEWART, ALEXANDER
|
MAYO CLINIC ARIZONA
|
|
Transcription and Splicing Dynamics in Single Cells
|
ZIA BC 011383
|
$754,029
|
$75,403
|
Larson, Daniel
|
CCR (NCI)
|
|
The thrombospondin1-TGF-beta axis in multiple myeloma
|
5R01CA175012-02
|
$598,327
|
$598,327
|
MURPHY-ULLRICH, JOANNE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
The Role of MMP13 in Multiple Myeloma Bone Disease
|
5R01CA175313-02
|
$331,098
|
$331,098
|
LENTZSCH, SUZANNE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of miRNA15a and 16-1 in Multiple Myeloma
|
5R01CA154648-05
|
$363,125
|
$363,125
|
GHOBRIAL, IRENE
|
DANA-FARBER CANCER INST
|
|
The Role of Exosome Heparanase and miRNAs as Biomarkers for Myeloma
|
5R21CA182861-02
|
$136,172
|
$136,172
|
BROWN, ELIZABETH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
The Role of Cereblon Pathways in Myeloma
|
5R01CA183968-02
|
$459,038
|
$459,038
|
STEWART, ALEXANDER
|
MAYO CLINIC ARIZONA
|
|
The role of c-Maf in Stem cells in Leukemia
|
5F31CA162770-05
|
|
$0
|
OKOYE, UJUNWA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
The role of c-Maf in Stem cells in Leukemia
|
6F31CA162770-06
|
$43,120
|
$21,560
|
OKOYE, UJUNWA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-21S1
|
$79,482
|
$795
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-21
|
$4,814,560
|
$48,146
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Induction of Gene-specific RNAi Against Cancer-associated Genes
|
ZIA BC 010613
|
$404,618
|
$20,231
|
Caplen, Natasha
|
CCR (NCI)
|
|
The Genetics of Susceptibility to Mouse Plasma Cell Tumors
|
ZIA BC 010008
|
$291,642
|
$145,821
|
Mock, Beverly
|
CCR (NCI)
|
|
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Therapy
|
ZIA SC 010288
|
$527,479
|
$131,870
|
Fowler, Daniel
|
CCR (NCI)
|
|
Targeting sphingosine kinase 2 for the treatment of multiple myeloma
|
1R01CA197792-01
|
$363,713
|
$363,713
|
KANG, YUBIN
|
DUKE UNIVERSITY
|
Total relevant funding to Multiple Myeloma for this search: $48,874,500
|